Mediators of Inflammation
Volume 2009 (2009), Article ID 826297, 7 pages
doi:10.1155/2009/826297
Clinical Study

Comparative Value of Simple Inflammatory Markers in the Prediction of Left Ventricular Systolic Dysfunction in Postacute Coronary Syndrome Patients

Panagiotis Aggelopoulos,1 Christina Chrysohoou,1 Christos Pitsavos,1 Lambros Papadimitriou,1 Catherine Liontou,1 Demosthenes Panagiotakos,2 Eleftherios Tsiamis,1 and Christodoulos Stefanadis1

1First Cardiology Clinic, School of Medicine, University of Athens, 115 28 Athens, Greece
2Department of Nutrition Science Dietetics, Harokopio University, 176 71 Athens, Greece

Received 6 February 2009; Revised 11 April 2009; Accepted 15 April 2009

Academic Editor: Dennis Daniel Taub

Copyright © 2009 Panagiotis Aggelopoulos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Dickstein, A. Cohen-Solal, G. Filippatos, et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM),” European Heart Journal, vol. 29, no. 19, pp. 2388–2442, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. P. G. Steg, O. H. Dabbous, L. J. Feldman, et al., “Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE),” Circulation, vol. 109, no. 4, pp. 494–499, 2004. View at Publisher · View at Google Scholar · View at PubMed
  3. M. I. Furman, J. M. Gore, F. A. Anderson, et al., “Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE),” American Heart Journal, vol. 147, no. 1, pp. 42–48, 2004. View at Publisher · View at Google Scholar
  4. M. Cesari, B. W. J. H. Penninx, A. B. Newman, et al., “Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study,” Circulation, vol. 108, no. 19, pp. 2317–2322, 2003. View at Publisher · View at Google Scholar · View at PubMed
  5. R. S. Vasan, L. M. Sullivan, R. Roubenoff, et al., “Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study,” Circulation, vol. 107, no. 11, pp. 1486–1491, 2003. View at Publisher · View at Google Scholar
  6. I. Kardys, A. M. Knetsch, G. S. Bleumink, et al., “C-reactive protein and risk of heart failure. The Rotterdam Study,” American Heart Journal, vol. 152, no. 3, pp. 514–520, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. H. Bahrami, D. A. Bluemke, R. Kronmal, et al., “Novel metabolic risk factors for incident heart failure and their relationship with obesity. The MESA (Multi-Ethnic Study of Atherosclerosis) Study,” Journal of the American College of Cardiology, vol. 51, no. 18, pp. 1775–1783, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. I. S. Anand, R. Latini, V. G. Florea, et al., “C-reactive protein in heart failure: prognostic value and the effect of Valsartan,” Circulation, vol. 112, no. 10, pp. 1428–1434, 2005. View at Publisher · View at Google Scholar · View at PubMed
  9. R. Dragu, S. Huri, R. Zuckerman, et al., “Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction,” Atherosclerosis, vol. 196, no. 1, pp. 405–412, 2008. View at Publisher · View at Google Scholar · View at PubMed
  10. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J. B. Young, and D. L. Mann, “Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD),” Journal of the American College of Cardiology, vol. 27, no. 5, pp. 1201–1206, 1996. View at Publisher · View at Google Scholar
  11. A. Deswal, N. J. Petersen, A. M. Feldman, J. B. Young, B. G. White, and D. L. Mann, “Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST),” Circulation, vol. 103, no. 16, pp. 2055–2059, 2001.
  12. K. Thygesen, J. S. Alpert, and H. D. White, “Universal definition of myocardial infarction,” European Heart Journal, vol. 28, no. 20, pp. 2525–2538, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. C. P. Cannon and E. Braunwald, “Unstable angina,” in Heart Disease: A Textbook of Cardiovascular Medicine, E. Braunwald, D. P. Zipes, and P. Libby, Eds., pp. 1232–1233, W. B. Saunders, London, UK, 6th edition, 2001.
  14. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002.
  15. L. Kyne, J. M. Hausdorff, E. Knight, L. Dukas, G. Azhar, and J. Y. Wei, “Neutrophilia and congestive heart failure after acute myocardial infarction,” American Heart Journal, vol. 139, no. 1, pp. 94–100, 2000. View at Publisher · View at Google Scholar
  16. C. Pitsavos, G. Kourlaba, D. Panagiotakos, et al., “Does smoking status affect the association between baseline white blood cell count and in-hospital mortality of patients presented with acute coronary syndrome? The Greek study of acute coronary syndromes (GREECS),” International Journal of Cardiology, vol. 125, no. 1, pp. 94–100, 2008.
  17. M. S. Sabatine, D. A. Morrow, C. P. Cannon, et al., “Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy,” Journal of the American College of Cardiology, vol. 40, no. 10, pp. 1761–1768, 2002. View at Publisher · View at Google Scholar
  18. H. V. Barron, C. P. Cannon, S. A. Murphy, E. Braunwald, and C. M. Gibson, “Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy,” Circulation, vol. 102, no. 19, pp. 2329–2334, 2000.
  19. P. Avanzas, R. Arroyo-Espliguero, J. Cosín-Sales, J. Quiles, E. Zouridakis, and J. C. Kaski, “Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina,” Atherosclerosis, vol. 175, no. 1, pp. 151–157, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. S. R. Jolly, W. J. Kane, B. G. Hook, G. D. Abrams, S. L. Kunkel, and B. R. Lucchesi, “Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion,” American Heart Journal, vol. 112, no. 4, pp. 682–690, 1986. View at Publisher · View at Google Scholar
  21. F. C. de Beer, C. R. Hind, K. M. Fox, R. M. Allan, A. Maseri, and M. B. Pepys, “Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction,” British Heart Journal, vol. 47, no. 3, pp. 239–243, 1982. View at Publisher · View at Google Scholar
  22. K. O. Pietila, A. P. Harmoinen, J. Jokiniitty, and A. I. Pasternack, “Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment,” European Heart Journal, vol. 17, no. 9, pp. 1345–1349, 1996.
  23. M. B. Pepys and G. M. Hirschfield, “C-reactive protein: a critical update,” The Journal of Clinical Investigation, vol. 111, no. 12, pp. 1805–1812, 2003. View at Publisher · View at Google Scholar
  24. M.-C. Tataru, J. Heinrich, R. Junker, et al., “C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris,” European Heart Journal, vol. 21, no. 12, pp. 1000–1008, 2000. View at Publisher · View at Google Scholar
  25. J. S. Zebrack, J. B. Muhlestein, B. D. Horne, and J. L. Anderson, “C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina,” Journal of the American College of Cardiology, vol. 39, no. 4, pp. 632–637, 2002. View at Publisher · View at Google Scholar
  26. A. R. Rudnicka, A. Rumley, G. D. O. Lowe, and D. P. Strachan, “Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population,” Circulation, vol. 115, no. 8, pp. 996–1003, 2007. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Dominguez-Rodriguez, M. Garcia-Gonzalez, P. Abreu-Gonzalez, J. Ferrer, and J. C. Kaski, “Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction,” The American Journal of Cardiology, vol. 97, no. 1, pp. 10–12, 2006. View at Publisher · View at Google Scholar · View at PubMed